STAT3 can restrain anti-tumour immune responses [22-27] and regulate key cancer-promoting inflammatory mediators, which can initiate or promote oncogenic transformation, and genetic and epigenetic changes in malignant cells [28,29]. This evidence concerns the gene STAT3 and cancer.